Yamanaka Shinya
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
Nature. 2009 Jul 2;460(7251):49-52. doi: 10.1038/nature08180.
Induced pluripotent stem cells offer unprecedented potential for disease research, drug screening, toxicology and regenerative medicine. However, the process of reprogramming is inefficient and often incomplete. Here I consider reasons for bottlenecks in induced pluripotent stem cell generation, and propose a model in which most or all cells have the potential to become pluripotent.
诱导多能干细胞为疾病研究、药物筛选、毒理学和再生医学提供了前所未有的潜力。然而,重编程过程效率低下且往往不完全。在此,我探讨了诱导多能干细胞生成过程中瓶颈的原因,并提出了一个模型,其中大多数或所有细胞都有成为多能细胞的潜力。